MedTrace Logo

MRI Parenchymal Enhancement: A New Marker of Breast Cancer Risk

NCT01649661 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 437

Last updated 2023-01-26

No results posted yet for this study

Summary

The purpose of this study is to learn about how a woman's health history influences what a normal breast looks like on an MRI. The investigators also want to learn about how the amount of different natural hormones a woman has affects how the breast looks on an MRI. The investigator's hope is that this will help to find women at a high-risk of breast cancer.

Conditions

  • Cancer Free Women

Interventions

BEHAVIORAL

questionnaire

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • University of Southern California

    collaborator OTHER

  • University of Toronto

    collaborator OTHER

  • Memorial Sloan Kettering Cancer Center

    lead OTHER

Principal Investigators

  • Janice Sung, MD · Memorial Sloan Kettering Cancer Center

Eligibility

Min Age
21 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-07-31
Primary Completion
2023-01-25
Completion
2023-01-25

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01649661 on ClinicalTrials.gov